All stock lists
Unlock the score
Golden Growers Cooperative (OTC:GGROU)
US · Delayed Price · Currency is USD
Consumer Defensive · Agricultural Farm Products
5.00+0.00 (+0.00%)
Market cap
$77.5M
Insider Score
Health Score
Listed since
Feb 24, 2014
Website
Insider Score
/ 100
GGROU Insider Score
Golden Growers Cooperative has a live Insider Score.
Scored on 2 qualifying trades from 1 insider in the last 90 days.
Financial Health Score
Strong
From GGROU’s reported statements · Q2 2026 (trailing 12 months)
Profitability15 / 20
Keeps a healthy share of every dollar it sells.
- Revenue
- $58.7M
- Net income
- $6.1M
- Net margin
- 10.4%
Leverage20 / 20
Little or no net debt.
- Total debt
- $0
- Cash
- $95K
- Debt / equity
- 0.00
Liquidity20 / 20
Comfortably covers what is due within a year.
- Current assets
- $2.4M
- Current liabilities
- $12K
- Current ratio
- 203.50
Cash generation13 / 20
Roughly cash-neutral.
- Operating cash flow
- $1.3M
- Free cash flow
- $1.3M
- FCF margin
- 2.2%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 15.5M
- Share growth (1y)
- 0.0%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
GGROU Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 14.86 M | 17.90 M | 13.65 M | 12.32 M | 16.22 M | 20.09 M |
| Revenue Growth (YoY) | -8.38 % | -10.88 % | -6.57 % | -8.37 % | 2.66 % | 10.72 % |
| Cost of Revenue | 14.88 M | 17.92 M | 13.61 M | 12.34 M | 16.24 M | 20.11 M |
| Gross Profit | -16.00 K | -16.00 K | 37.00 K | -17.00 K | -17.00 K | -17.00 K |
| SG&A Expense | 144.00 K | 232.00 K | 135.00 K | 139.00 K | 138.00 K | 258.00 K |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 144.00 K | 232.00 K | 135.00 K | 139.00 K | -1.42 M | 258.00 K |
| Operating Income | -160.00 K | -248.00 K | -98.00 K | -156.00 K | 1.41 M | 1.51 M |
| Pretax Income | 1.48 M | 1.42 M | 1.57 M | 1.41 M | 1.49 M | 1.59 M |
| Tax Provision | 0.00 | -208.00 K | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 1.48 M | 1.63 M | 1.57 M | 1.41 M | 1.49 M | 1.59 M |
| EPS (Basic) | 0.10 | 0.09 | 0.10 | 0.09 | 0.10 | 0.10 |
| EPS (Diluted) | 0.10 | 0.09 | 0.10 | 0.09 | 0.10 | 0.10 |
| Shares Outstanding | 15.49 M | 15.49 M | 15.49 M | 15.49 M | 15.49 M | 15.49 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
